During the past decade, General Hospital Dubrovnik conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "General Hospital Dubrovnik" #1 sponsor was "Children's Hospital Srebrnjak" with 1 trials, followed by "Daiichi Sankyo, Inc." with 1 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "General Hospital Dubrovnik" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "General Hospital Dubrovnik" #1 collaborator was "Clinical Hospital Center, Split" with 1 trials as a collaborator, "General Hospital Dubrovnik" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Institute for Medical Research and Occupational Health, Zagreb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "General Hospital Dubrovnik" are "Anaesthesia" (1 trials), "Atrial Fibrillation" (1 trials), "COPD" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Lactation" (1 trials). Many other conditions were trialed in "General Hospital Dubrovnik" in a lesser frequency.

Most popular intervention types in "General Hospital Dubrovnik" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (1 trials), "Docetaxel" (1 trials), "Edoxaban" (1 trials), "isoflurane" (1 trials) and "sevoflurane" (1 trials). Other intervention names were less common.

The vast majority of trials in "General Hospital Dubrovnik" are 5 trials for "All" genders.

Currently, there are NaN active trials in "General Hospital Dubrovnik". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in General Hospital Dubrovnik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General Hospital Dubrovnik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".